Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.

Gaustadnes M, Rüdiger N, Møller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J.

Blood Coagul Fibrinolysis. 1999 Jul;10(5):251-9.

PMID:
10456616
2.

No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.

Rintelen C, Mannhalter C, Lechner K, Eichinger S, Kyrle PA, Papagiannopoulos M, Schneider B, Pabinger I.

Blood Coagul Fibrinolysis. 1999 Mar;10(2):101-5.

PMID:
10192659
3.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

4.
5.

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):511-8.

6.

Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.

Varela ML, Adamczuk YP, Forastiero RR, Martinuzzo ME, Cerrato GS, Pombo G, Carreras LO.

Thromb Res. 2001 Dec 1;104(5):317-24.

PMID:
11738073
7.

Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.

Morelli VM, Lourenço DM, D'Almeida V, Franco RF, Miranda F, Zago MA, Noguti MA, Cruz E, Kerbauy J.

Blood Coagul Fibrinolysis. 2002 Apr;13(3):271-5.

PMID:
11943942
8.

Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis.

Larsen TB, Nørgaard-Pedersen B, Lundemose JB, Rüdiger N, Gaustadnes M, Brandslund I.

Thromb Res. 2000 May 15;98(4):233-9.

PMID:
10822069
9.

Factor V Leiden, prothrombin 20210G --> A, methylenetetrahydrofolate reductase 677C --> T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism.

Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, Novak-Antolic Z.

Eur J Obstet Gynecol Reprod Biol. 2003 Dec 10;111(2):157-63.

PMID:
14597244
10.

Hereditary thrombophilia in ethnic Omani patients.

Pathare A, Al Kindi S, Al Haddabi H, Dennison D, Bayoumi R, Muralitharan S.

Am J Hematol. 2006 Feb;81(2):101-6.

11.

AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.

Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.

Haematologica. 2008 May;93(5):729-34. doi: 10.3324/haematol.12271. Epub 2008 Apr 2.

12.

Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?

Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.

Thromb Res. 2008;121(6):743-50. Epub 2007 Sep 4.

PMID:
17804043
13.

Venous thromboembolism in young patients from western India: a study.

Ghosh K, Shetty S, Madkaikar M, Pawar A, Nair S, Khare A, Pathare A, Jijina F, Mohanty D.

Clin Appl Thromb Hemost. 2001 Apr;7(2):158-65.

PMID:
11292195
14.

Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.

De Stefano V, Casorelli I, Rossi E, Zappacosta B, Leone G.

Semin Thromb Hemost. 2000;26(3):305-11. Review.

PMID:
11011848
15.

Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Vossen CY, Conard J, Fontcuberta J, Makris M, VAN DER Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR.

J Thromb Haemost. 2005 Mar;3(3):459-64.

16.
17.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
18.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
19.

Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.

Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM.

Blood. 1998 Oct 1;92(7):2353-8.

20.

Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.

Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):36-40.

PMID:
10726047
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk